<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03920670</url>
  </required_header>
  <id_info>
    <org_study_id>18-011298</org_study_id>
    <nct_id>NCT03920670</nct_id>
  </id_info>
  <brief_title>Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit</brief_title>
  <official_title>Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this investigation is to compare the performance of two quantitative monitors
      utilized on post-anesthesia recovering patients. The ToFscan (Draeger Medical Inc., Telford,
      PA) represents one of the few standalone acceleromyography (AMG)-based quantitative monitors
      available for routine clinical use in the United States. The TetraGraph (Senzime AB, Uppsala,
      Sweden) is a standalone electromyography (EMG)-based quantitative monitor that recently
      received Conformité Européene (CE) approval. While both of these quantitative monitors can be
      utilized to guide intraoperative NMBA re-dosing and confirm recovery, they provide their
      objective data via drastically different techniques.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 28, 2019</start_date>
  <completion_date type="Anticipated">January 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Consistency in values obtained by ToFscan and TetraGraph</measure>
    <time_frame>up to 10 hours postoperatively</time_frame>
    <description>Obtain ToFscan values and TetraGraph values simultaneously in the recovery period simultaneously (same measuring units).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with incomplete neuromuscular blockade reversal</measure>
    <time_frame>up to 10 hours postoperatively</time_frame>
    <description>Identify patients who demonstrate TOF reading below 90% in the recovery period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's reported discomfort with use of devices</measure>
    <time_frame>up to 10 hours postoperatively</time_frame>
    <description>Number of patients reporting discomfort associated with use of either device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Residual Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TetraGraph on dominant arm, ToFscan on non-dominant arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TetraGraph on non-dominant arm, ToFscan on dominant arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular stimulation</intervention_name>
    <description>AMG and EMG neuromuscular blockade monitoring</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Age &gt; or = 18 years old

          -  Patients willing to participate and provide an informed consent

          -  Patients undergoing an elective surgical procedure that requires use of
             non-depolarizing NMBA agents administered intraoperatively.

        Exclusion Criteria

          -  Patients with unilateral disorders, such as stroke, carpal tunnel syndrome, broken
             wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.

          -  Patients with systemic neuromuscular diseases such as myasthenia gravis

          -  Patients with significant organ dysfunction that can significantly affect
             pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal
             impairment or end-stage liver disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J Ross Renew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Debrecen</name>
      <address>
        <city>Debrecen</city>
        <zip>4031</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 13, 2019</study_first_submitted>
  <study_first_submitted_qc>April 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>J. Ross Renew, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Neuromuscular Blockade</keyword>
  <keyword>ToFscan</keyword>
  <keyword>Tetragraph</keyword>
  <keyword>AMG</keyword>
  <keyword>EMG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delayed Emergence from Anesthesia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

